跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,344 条关于
“CHO-DG44”
全部
5,344
临床试验
2,269
药物
1,004
机构
1,414
资讯
657
去年
Aragen to Launch GMP Biologics Manufacturing in India with Advanced Fed-Batch Platform
去年
Asimov Expands Strategic Partnerships to Accelerate Biologics Development Through CHO Edge Platform
去年
CHO Plus Secures U.S. Patent for Engineered Yeast Cell Technology to Boost Protein Production
去年
CHO Plus Secures $10.4M BARDA Contract to Develop Cell Lines for Filovirus Monoclonal Antibody Production
去年
Yale Team Awarded $76M NIH Grant to Study Schizophrenia Risk in Youth
9个月前
Chitose Laboratory and Fujifilm Biosciences Form Strategic Alliance to Advance Biopharmaceutical Manufacturing
6个月前
Asimov Partners with Score Pharma to Develop Enhanced Anti-HER2 Antibody Therapeutics for Breast Cancer
去年
WuXi Biologics Launches WuXia293Stable Platform to Address Manufacturing Challenges for Complex Biologics
上个月
Kyungdong Pharmaceutical and Asimov Complete AI-Driven Cell Line Development for Next-Generation Biosimilar Antibody
去年
Cornell Researchers Engineer Bacteria to Produce Therapeutic Antibodies at Lower Cost
第 1 页,共 66 页
上一页
下一页